Pronokal Sodium
Natural health product licensed in Canada
- Licence holder
- Pronokal Canada
- NPN or DIN-HM
- 80036375
- Status
- Inactive licence
- Licence date
- 11 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Sodium Source : Chlorure de sodium | 195 mg |
Non-medicinal ingredients
Eau purifiée, Dioxyde de titane, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Utiliser pour maintenir des niveaux normaux de sodium dans le cadre de la méthode Pronokal.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036375
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.